Cargando…
Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
Autor principal: | Grant-Kels, Jane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195091/ https://www.ncbi.nlm.nih.gov/pubmed/32348824 http://dx.doi.org/10.1016/j.jaad.2020.04.112 |
Ejemplares similares
-
Does hydroxychloroquine combat COVID-19? A timeline of evidence
por: Alia, Erisa, et al.
Publicado: (2020) -
Risks of hydroxychloroquine use for COVID-19 prophylaxis
por: Sachdeva, Muskaan, et al.
Publicado: (2020) -
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020) -
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020) -
Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)